Becker M A, Kostel P J, Meyer L J, Seegmiller J E
Proc Natl Acad Sci U S A. 1973 Oct;70(10):2749-52. doi: 10.1073/pnas.70.10.2749.
Among affected members of a family (B. family) with excessive purine production and gout, activity of phosphoribosylpyrophosphate synthetase (EC 2.7.6.1) is 2.5- to 3.0-fold higher than among normal people. The molecular basis for this increased enzyme activity was studied. Antibody to purified human phosphoribosylpyrophosphate synthetase of erythrocytes was obtained from immunized rabbits. Studies with the IgG fraction of this antiserum show the presence of normal quantities of immunoreactive enzyme, but 2.5- to 3.0-fold higher activity per molecule in affected members of the B. family. In addition, by use of a stain for phosphoribosylpyrophosphate synthetase activity, a difference in electrophoretic mobility was demonstrated on cellulose acetate gel between the partially purified enzyme from normal people and an affected member of the B. family. These studies suggest that the enzyme aberration responsible for purine overproduction and gout in the B. family results from a structurally altered enzyme with increased activity per molecule.
在一个嘌呤产生过多且患有痛风的家族(B家族)的患病成员中,磷酸核糖焦磷酸合成酶(EC 2.7.6.1)的活性比正常人高2.5至3.0倍。对这种酶活性增加的分子基础进行了研究。从免疫兔中获得了针对纯化的人红细胞磷酸核糖焦磷酸合成酶的抗体。用该抗血清的IgG组分进行的研究表明,免疫反应性酶的量正常,但B家族患病成员中每个分子的活性高2.5至3.0倍。此外,通过使用磷酸核糖焦磷酸合成酶活性染色剂,在醋酸纤维素凝胶上证明了正常人的部分纯化酶与B家族的一名患病成员之间的电泳迁移率存在差异。这些研究表明,导致B家族嘌呤产生过多和痛风的酶异常是由一种结构改变且每个分子活性增加的酶引起的。